Effect of Na/K/2Cl transporter inhibition with piretanide on postischemic kidney function.
Abendroth
D
D
Department of Thoracic and Vascular Surgery, University of Ulm, Germany.
Prestel
R
R
Storck
M
M
Steinbach
G
G
Pooth
R
R
Hammer
C
C
D000818:Animals; D002352:Carrier Proteins / Q000037:antagonists & inhibitors*; D003404:Creatinine / Q000378:metabolism; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology; D007511:Ischemia; D007668:Kidney / Q000098:blood supply / Q000187:drug effects / Q000502:physiology*; D009926:Organ Preservation; D010101:Oxygen Consumption / Q000187:drug effects; D015424:Reperfusion; D028021:Sodium-Potassium-Chloride Symporters; D013449:Sulfonamides / Q000494:pharmacology*; D013552:Swine; D013997:Time Factors
D002352:Carrier Proteins; D004232:Diuretics; D028021:Sodium-Potassium-Chloride Symporters; D013449:Sulfonamides; D003404:Creatinine; C015451:piretanide